Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2614196019 | Bendroflumethiazide + propranolol (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 2616802012 | Bendroflumethiazide + propranolol | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 2692262011 | Bendroflumethiazide + Propranolol | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3503324015 | Product containing bendroflumethiazide and propranolol (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3503325019 | Bendroflumethiazide and propranolol | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3503326018 | Product containing bendroflumethiazide and propranolol | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3668032013 | Bendroflumethiazide and propranolol product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3713421015 | Bendroflumethiazide- and propranolol-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bendroflumethiazide- and propranolol-containing product | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
| Bendroflumethiazide- and propranolol-containing product | Is a | Bendroflumethiazide-containing product | true | Inferred relationship | Some | ||
| Bendroflumethiazide- and propranolol-containing product | Is a | Propranolol-containing product | true | Inferred relationship | Some | ||
| Bendroflumethiazide- and propranolol-containing product | Has active ingredient | Propranolol | true | Inferred relationship | Some | 1 | |
| Bendroflumethiazide- and propranolol-containing product | Has active ingredient | Bendroflumethiazide | true | Inferred relationship | Some | 2 | |
| Bendroflumethiazide- and propranolol-containing product | Is a | Propranolol+diuretic | false | Inferred relationship | Some | ||
| Bendroflumethiazide- and propranolol-containing product | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bendroflumethiazide- and propranolol-containing product in oral dose form | Is a | True | Bendroflumethiazide- and propranolol-containing product | Inferred relationship | Some | |
| Bendroflumethiazide and propranolol only product | Is a | True | Bendroflumethiazide- and propranolol-containing product | Inferred relationship | Some | |
| Bendroflumethiazide 2.5 mg and propranolol hydrochloride 80 mg oral capsule | Is a | False | Bendroflumethiazide- and propranolol-containing product | Inferred relationship | Some | |
| Propranolol hydrochloride 160mg / bendrofluazide 5mg m/r capsule | Is a | False | Bendroflumethiazide- and propranolol-containing product | Inferred relationship | Some | |
| Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule | Is a | False | Bendroflumethiazide- and propranolol-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR